PharMerica Earnings: Everything You Must Know Now
PharMerica Corporation (NYSE:PMC) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.
PharMerica Corporation Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 53.33% to $0.46 in the quarter versus EPS of $0.30 in the year-earlier quarter.
Revenue: Decreased 11.85% to $439.8 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: PharMerica Corporation reported adjusted EPS income of $0.46 per share. By that measure, the company beat the mean analyst estimate of $0.34. It beat the average revenue estimate of $436.74 million.
Quoting Management: Greg Weishar, PharMerica Corporation’s Chief Executive Officer, said, “This quarter’s results demonstrate the success of ongoing efforts to improve operations and profitability. The Company achieved record quarterly pharmacy gross margin and Adjusted EBITDA margin of 19.2% and 7.9%, respectively. On a sequential-quarter basis these margins increased 170 and 120 basis points, respectively. Adjusted diluted earnings per share increased 39% as compared to first quarter of 2012, and increased 28% on a sequential-quarter basis.”
Key Stats (on next page)…